Fluorine in PDB 5csw: B-Raf in Complex with Dabrafenib
Enzymatic activity of B-Raf in Complex with Dabrafenib
All present enzymatic activity of B-Raf in Complex with Dabrafenib:
2.7.11.1;
Protein crystallography data
The structure of B-Raf in Complex with Dabrafenib, PDB code: 5csw
was solved by
G.Bader,
H.Stadtmuller,
S.Steurer,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
100.73 /
2.66
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
114.359,
48.095,
101.168,
90.00,
95.32,
90.00
|
R / Rfree (%)
|
21.7 /
28.2
|
Other elements in 5csw:
The structure of B-Raf in Complex with Dabrafenib also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the B-Raf in Complex with Dabrafenib
(pdb code 5csw). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
B-Raf in Complex with Dabrafenib, PDB code: 5csw:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 1 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:45.2
occ:1.00
|
F39
|
A:P06801
|
0.0
|
45.2
|
1.0
|
C32
|
A:P06801
|
1.4
|
40.5
|
1.0
|
C31
|
A:P06801
|
2.4
|
40.3
|
1.0
|
C30
|
A:P06801
|
2.4
|
39.4
|
1.0
|
N40
|
A:P06801
|
2.7
|
38.4
|
1.0
|
C16
|
A:P06801
|
2.9
|
41.3
|
1.0
|
N
|
A:ASP594
|
3.0
|
25.9
|
1.0
|
O
|
A:HOH905
|
3.1
|
34.4
|
1.0
|
N15
|
A:P06801
|
3.1
|
44.5
|
1.0
|
CA
|
A:ASP594
|
3.4
|
29.9
|
1.0
|
CB
|
A:ASP594
|
3.5
|
29.7
|
1.0
|
C33
|
A:P06801
|
3.6
|
37.1
|
1.0
|
C35
|
A:P06801
|
3.7
|
37.0
|
1.0
|
CZ
|
A:PHE583
|
3.9
|
38.6
|
1.0
|
C12
|
A:P06801
|
3.9
|
45.2
|
1.0
|
C
|
A:GLY593
|
3.9
|
23.7
|
1.0
|
CE2
|
A:PHE583
|
3.9
|
36.5
|
1.0
|
OD1
|
A:ASP594
|
3.9
|
33.1
|
1.0
|
CD2
|
A:LEU514
|
4.1
|
22.2
|
1.0
|
C14
|
A:P06801
|
4.1
|
50.4
|
1.0
|
C37
|
A:P06801
|
4.1
|
31.6
|
1.0
|
S42
|
A:P06801
|
4.2
|
34.4
|
1.0
|
CG
|
A:ASP594
|
4.3
|
30.5
|
1.0
|
CA
|
A:GLY593
|
4.3
|
23.6
|
1.0
|
NZ
|
A:LYS483
|
4.3
|
36.0
|
1.0
|
O55
|
A:P06801
|
4.4
|
28.1
|
1.0
|
C4
|
A:P06801
|
4.7
|
36.6
|
1.0
|
O54
|
A:P06801
|
4.7
|
36.9
|
1.0
|
C2
|
A:P06801
|
4.7
|
41.8
|
1.0
|
C26
|
A:P06801
|
4.7
|
45.8
|
1.0
|
C
|
A:ASP594
|
4.8
|
32.6
|
1.0
|
O
|
A:GLY593
|
4.9
|
24.5
|
1.0
|
S13
|
A:P06801
|
4.9
|
43.0
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 2 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:41.6
occ:1.00
|
F52
|
A:P06801
|
0.0
|
41.6
|
1.0
|
C49
|
A:P06801
|
1.3
|
40.0
|
1.0
|
C50
|
A:P06801
|
2.4
|
38.9
|
1.0
|
C43
|
A:P06801
|
2.4
|
35.7
|
1.0
|
O54
|
A:P06801
|
2.6
|
36.9
|
1.0
|
S42
|
A:P06801
|
3.0
|
34.4
|
1.0
|
CD1
|
A:LEU505
|
3.1
|
14.6
|
1.0
|
CG2
|
A:ILE527
|
3.3
|
19.1
|
1.0
|
CG2
|
A:THR529
|
3.6
|
14.9
|
1.0
|
C47
|
A:P06801
|
3.6
|
38.8
|
1.0
|
C46
|
A:P06801
|
3.6
|
38.9
|
1.0
|
C33
|
A:P06801
|
3.6
|
37.1
|
1.0
|
N40
|
A:P06801
|
4.0
|
38.4
|
1.0
|
CD1
|
A:ILE527
|
4.0
|
27.4
|
1.0
|
CB
|
A:ILE527
|
4.1
|
22.8
|
1.0
|
C44
|
A:P06801
|
4.1
|
41.5
|
1.0
|
O55
|
A:P06801
|
4.2
|
28.1
|
1.0
|
C31
|
A:P06801
|
4.3
|
40.3
|
1.0
|
CG
|
A:LEU505
|
4.3
|
26.3
|
1.0
|
CD2
|
A:LEU505
|
4.3
|
21.6
|
1.0
|
CD
|
A:LYS483
|
4.7
|
22.2
|
1.0
|
CG1
|
A:ILE527
|
4.7
|
24.9
|
1.0
|
C37
|
A:P06801
|
4.7
|
31.6
|
1.0
|
F53
|
A:P06801
|
4.7
|
31.6
|
1.0
|
CB
|
A:LEU505
|
5.0
|
27.7
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 3 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:31.6
occ:1.00
|
F53
|
A:P06801
|
0.0
|
31.6
|
1.0
|
C46
|
A:P06801
|
1.3
|
38.9
|
1.0
|
C44
|
A:P06801
|
2.4
|
41.5
|
1.0
|
C43
|
A:P06801
|
2.4
|
35.7
|
1.0
|
O55
|
A:P06801
|
2.7
|
28.1
|
1.0
|
S42
|
A:P06801
|
2.9
|
34.4
|
1.0
|
N40
|
A:P06801
|
3.1
|
38.4
|
1.0
|
CA
|
A:GLY593
|
3.2
|
23.6
|
1.0
|
C47
|
A:P06801
|
3.6
|
38.8
|
1.0
|
C49
|
A:P06801
|
3.6
|
40.0
|
1.0
|
N
|
A:ASP594
|
3.7
|
25.9
|
1.0
|
CE1
|
A:PHE595
|
3.7
|
49.2
|
1.0
|
C
|
A:GLY593
|
3.8
|
23.7
|
1.0
|
CZ
|
A:PHE595
|
3.8
|
42.8
|
1.0
|
CD1
|
A:PHE595
|
3.9
|
42.3
|
1.0
|
CE2
|
A:PHE595
|
4.1
|
39.5
|
1.0
|
C50
|
A:P06801
|
4.1
|
38.9
|
1.0
|
CG
|
A:PHE595
|
4.2
|
41.8
|
1.0
|
CD2
|
A:LEU514
|
4.2
|
22.2
|
1.0
|
O
|
A:ILE592
|
4.2
|
27.1
|
1.0
|
CD2
|
A:PHE595
|
4.3
|
38.8
|
1.0
|
CB
|
A:LEU514
|
4.3
|
19.3
|
1.0
|
O54
|
A:P06801
|
4.3
|
36.9
|
1.0
|
C31
|
A:P06801
|
4.3
|
40.3
|
1.0
|
N
|
A:GLY593
|
4.4
|
25.2
|
1.0
|
N
|
A:PHE595
|
4.4
|
37.0
|
1.0
|
CA
|
A:ASP594
|
4.7
|
29.9
|
1.0
|
F52
|
A:P06801
|
4.7
|
41.6
|
1.0
|
C
|
A:ILE592
|
4.7
|
24.7
|
1.0
|
CG
|
A:LEU514
|
4.7
|
22.6
|
1.0
|
O
|
A:GLY593
|
4.8
|
24.5
|
1.0
|
CD2
|
A:LEU505
|
4.8
|
21.6
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 4 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:39.2
occ:1.00
|
F39
|
B:P06801
|
0.0
|
39.2
|
1.0
|
C32
|
B:P06801
|
1.4
|
37.0
|
1.0
|
C31
|
B:P06801
|
2.4
|
43.1
|
1.0
|
C30
|
B:P06801
|
2.4
|
37.1
|
1.0
|
N40
|
B:P06801
|
2.8
|
40.1
|
1.0
|
C16
|
B:P06801
|
2.9
|
40.4
|
1.0
|
N
|
B:ASP594
|
2.9
|
33.8
|
1.0
|
N15
|
B:P06801
|
3.0
|
40.8
|
1.0
|
O
|
B:HOH906
|
3.1
|
36.3
|
1.0
|
CA
|
B:ASP594
|
3.4
|
38.4
|
1.0
|
C33
|
B:P06801
|
3.7
|
48.6
|
1.0
|
CB
|
B:ASP594
|
3.7
|
38.6
|
1.0
|
C35
|
B:P06801
|
3.7
|
41.4
|
1.0
|
C12
|
B:P06801
|
4.0
|
44.2
|
1.0
|
C
|
B:GLY593
|
4.0
|
29.6
|
1.0
|
CZ
|
B:PHE583
|
4.0
|
34.3
|
1.0
|
CE2
|
B:PHE583
|
4.0
|
31.5
|
1.0
|
C14
|
B:P06801
|
4.1
|
42.6
|
1.0
|
C37
|
B:P06801
|
4.1
|
46.5
|
1.0
|
OD1
|
B:ASP594
|
4.2
|
38.1
|
1.0
|
CA
|
B:GLY593
|
4.3
|
26.1
|
1.0
|
NZ
|
B:LYS483
|
4.3
|
22.9
|
1.0
|
S42
|
B:P06801
|
4.3
|
39.8
|
1.0
|
CD2
|
B:LEU514
|
4.4
|
13.9
|
1.0
|
CG
|
B:ASP594
|
4.4
|
39.1
|
1.0
|
C26
|
B:P06801
|
4.6
|
31.8
|
1.0
|
O55
|
B:P06801
|
4.7
|
35.0
|
1.0
|
C4
|
B:P06801
|
4.8
|
40.9
|
1.0
|
C
|
B:ASP594
|
4.8
|
41.3
|
1.0
|
C2
|
B:P06801
|
4.8
|
45.0
|
1.0
|
S13
|
B:P06801
|
4.9
|
45.8
|
1.0
|
O54
|
B:P06801
|
4.9
|
41.1
|
1.0
|
C17
|
B:P06801
|
5.0
|
41.6
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 5 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:41.5
occ:1.00
|
F52
|
B:P06801
|
0.0
|
41.5
|
1.0
|
C49
|
B:P06801
|
1.3
|
38.5
|
1.0
|
C43
|
B:P06801
|
2.4
|
37.2
|
1.0
|
C50
|
B:P06801
|
2.4
|
39.2
|
1.0
|
O54
|
B:P06801
|
2.6
|
41.1
|
1.0
|
S42
|
B:P06801
|
3.0
|
39.8
|
1.0
|
CG2
|
B:ILE527
|
3.2
|
12.5
|
1.0
|
CD1
|
B:LEU505
|
3.3
|
17.3
|
1.0
|
CG2
|
B:THR529
|
3.3
|
23.0
|
1.0
|
C33
|
B:P06801
|
3.5
|
48.6
|
1.0
|
C46
|
B:P06801
|
3.6
|
34.9
|
1.0
|
C47
|
B:P06801
|
3.6
|
38.2
|
1.0
|
N40
|
B:P06801
|
4.0
|
40.1
|
1.0
|
C44
|
B:P06801
|
4.1
|
36.4
|
1.0
|
CB
|
B:ILE527
|
4.1
|
15.2
|
1.0
|
C31
|
B:P06801
|
4.2
|
43.1
|
1.0
|
CD1
|
B:ILE527
|
4.2
|
11.5
|
1.0
|
O55
|
B:P06801
|
4.2
|
35.0
|
1.0
|
CG
|
B:LEU505
|
4.5
|
21.9
|
1.0
|
C37
|
B:P06801
|
4.5
|
46.5
|
1.0
|
CD2
|
B:LEU505
|
4.6
|
15.5
|
1.0
|
F53
|
B:P06801
|
4.7
|
38.4
|
1.0
|
CB
|
B:THR529
|
4.7
|
24.8
|
1.0
|
CG1
|
B:ILE527
|
4.8
|
13.1
|
1.0
|
CD
|
B:LYS483
|
4.9
|
21.8
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5csw
Go back to
Fluorine Binding Sites List in 5csw
Fluorine binding site 6 out
of 6 in the B-Raf in Complex with Dabrafenib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of B-Raf in Complex with Dabrafenib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:38.4
occ:1.00
|
F53
|
B:P06801
|
0.0
|
38.4
|
1.0
|
C46
|
B:P06801
|
1.3
|
34.9
|
1.0
|
C43
|
B:P06801
|
2.3
|
37.2
|
1.0
|
C44
|
B:P06801
|
2.4
|
36.4
|
1.0
|
O55
|
B:P06801
|
2.6
|
35.0
|
1.0
|
S42
|
B:P06801
|
2.9
|
39.8
|
1.0
|
N40
|
B:P06801
|
3.1
|
40.1
|
1.0
|
CA
|
B:GLY593
|
3.3
|
26.1
|
1.0
|
CD1
|
B:PHE595
|
3.5
|
52.3
|
1.0
|
CE1
|
B:PHE595
|
3.5
|
50.3
|
1.0
|
C49
|
B:P06801
|
3.6
|
38.5
|
1.0
|
C47
|
B:P06801
|
3.6
|
38.2
|
1.0
|
C
|
B:GLY593
|
3.9
|
29.6
|
1.0
|
N
|
B:ASP594
|
4.0
|
33.8
|
1.0
|
CG
|
B:PHE595
|
4.0
|
50.4
|
1.0
|
CZ
|
B:PHE595
|
4.0
|
47.7
|
1.0
|
C50
|
B:P06801
|
4.1
|
39.2
|
1.0
|
O
|
B:ILE592
|
4.2
|
26.4
|
1.0
|
O54
|
B:P06801
|
4.3
|
41.1
|
1.0
|
C31
|
B:P06801
|
4.4
|
43.1
|
1.0
|
CD2
|
B:LEU514
|
4.4
|
13.9
|
1.0
|
CD2
|
B:PHE595
|
4.5
|
49.8
|
1.0
|
N
|
B:PHE595
|
4.5
|
45.0
|
1.0
|
CE2
|
B:PHE595
|
4.5
|
47.4
|
1.0
|
CB
|
B:LEU514
|
4.5
|
18.3
|
1.0
|
N
|
B:GLY593
|
4.6
|
24.7
|
1.0
|
F52
|
B:P06801
|
4.7
|
41.5
|
1.0
|
CB
|
B:PHE595
|
4.7
|
46.3
|
1.0
|
O
|
B:GLY593
|
4.8
|
30.4
|
1.0
|
C
|
B:ILE592
|
4.8
|
24.1
|
1.0
|
CA
|
B:ASP594
|
5.0
|
38.4
|
1.0
|
|
Reference:
I.C.Waizenegger,
A.Baum,
S.Steurer,
H.Stadtmuller,
G.Bader,
O.Schaaf,
P.Garin-Chesa,
A.Schlattl,
N.Schweifer,
C.Haslinger,
F.Colbatzky,
S.Mousa,
A.Kalkuhl,
N.Kraut,
G.R.Adolf.
A Novel Raf Kinase Inhibitor with Dfg-Out-Binding Mode: High Efficacy in Braf-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation. Mol.Cancer Ther. V. 15 354 2016.
ISSN: ESSN 1538-8514
PubMed: 26916115
DOI: 10.1158/1535-7163.MCT-15-0617
Page generated: Thu Aug 1 08:33:40 2024
|